Loading
NASDAQHealthcareMedical - Devices
Latest quote
$22.115
+$0.385 · +1.77%
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Regular session
$22.115
+$0.385 · +1.77%
Regular session · ET · Market data may be delayed.
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Day range
Current $22.115
52-week range
Current $22.115
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
90
Deep Value
Sentiment
77
Bullish
Risk
44
Elevated Risk
Momentum
63
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Day range
Current $22.115
52-week range
Current $22.115
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 329.52M USD | 292.98M USD | 274.42M USD | 246.79M USD | 208.06M USD |
| Cost of goods sold | 81.82M USD | 76.3M USD | 79.29M USD | 70.81M USD | 59.84M USD |
| Gross profit | 247.7M USD | 216.69M USD | 195.13M USD | 175.98M USD | 148.21M USD |
| Research and development | 8.48M USD | 8.83M USD | 7.82M USD | 7.09M USD | 5.66M USD |
| Selling, general, and administrative | 209.94M USD | 183.14M USD | 169.19M USD | 167.21M USD | 143.58M USD |
| Operating expenses | 218.42M USD | 194.51M USD | 177.09M USD | 188.73M USD | 149.98M USD |
| Interest income | 3.1M USD | 3.38M USD | 1.87M USD | 60K USD | — |
| Interest expense | 1.04M USD | 2.09M USD | 4.15M USD | 2.79M USD | — |
| Depreciation and amortization | 6.64M USD | 6.8M USD | 6.5M USD | 14.43M USD | 3.68M USD |
| Operating income | 29.28M USD | 22.18M USD | 18.04M USD | −12.76M USD | −1.76M USD |
| Net income | 19.09M USD | 16.96M USD | 28.52M USD | −17.87M USD | −11.81M USD |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$40.00
80.87% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI19.34M0.00%2.3T USD0.03%$375.9-0.45%
iShares Russell 2000 ETFIWM12.97M0.02%80.51B USD0.19%$290.73-1.34%
Vanguard Extended Market ETFVXF7.29M0.01%93.7B USD0.05%$238.84-1.04%
iShares Russell 2000 Growth ETFIWO3.93M0.03%14.7B USD0.24%$371.25-1.55%
Vanguard Russell 2000 ETFVTWO3.61M0.02%17.4B USD0.06%$117.55-1.34%
Dimensional - US Targeted Value ETFDFAT3.2M0.02%14.53B USD0.28%$70.385-0.80%
Fidelity Enhanced Small Cap ETFFESM3.03M0.05%6.49B USD0.28%$46.545-1.16%
Avantis U.S. Small Cap Value ETFAVUV2.9M0.01%31.45B USD0.25%$124.32-0.80%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWODimensional - US Targeted Value ETFDFATFidelity Enhanced Small Cap ETFFESMAvantis U.S. Small Cap Value ETFAVUVAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
